BPLPHARMA

HealthcareDrug Manufacturers - Specialty & Generic0
Bharat Parenterals Ltd
₹1,397.1
Previous trading day close · Data updates nightly
50/100
Below AvgResearch Score
Market Cap
N/A
P/E Ratio
-116.80
Negative earnings
P/B Ratio
1.76
Reasonable
ROE
-4.4%
Weak
ROCE
-1.9%
Average
Debt / Equity
0.47
Low debt
Div. Yield
0.1%
EV/EBITDA
66.93
Expensive
Data as of previous trading day close · Updated nightly
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated nightly
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
41/100
Growth
Revenue, EPS, profit growth
65/100
Valuation
PE, PB, EV/EBITDA vs sector
45/100
Risk
Debt levels, volatility, coverage
52/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-116.80(Negative earnings)
Forward P/E
N/A
P/B Ratio
1.76(Reasonable)
P/S Ratio
2.69(Good)
EV/EBITDA
66.93(Expensive)
Dividend Yield
0.1%
5Y CAGR
31.2%(High growth)
Revenue Growth
-19.2%(Moderate)
Profitability
ROE
-4.4%(Average)
ROCE
-1.9%(Average)
ROA
-2.2%(Average)
Net Margin
-4.8%(Low)
EBITDA Margin
7.3%
Financial Health
Debt to Equity
0.47(Low debt)
Current Ratio
1.62(Healthy)
Quick Ratio
1.29(Good)
Interest Coverage
-0.71x(Low)
Technical Indicators
Based on previous trading day close
Volume
4.5K
Shareholding Pattern
Promoter
67.2%
High confidence
FII
0.1%
DII / MF
1.1%
Share BPLPHARMA
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates nightly after market close. Please consult a SEBI-registered advisor before investing.
BPLPHARMA Share Price - ₹1397.10 | Research Score & Analysis | StockSage Pro